Stock Market Reviews

RLAY (Relay Therapeutics, Inc.) News

Get the latest news, insights, and market updates on RLAY (Relay Therapeutics, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Wall Street Analysts Think Relay Therapeutics (RLAY) Could Surge 86.05%: Read This Before Placing a Bet
  The consensus price target hints at an 86.1% upside potential for Relay Therapeutics (RLAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
  Oct 30, 2025 - $RLAY
• Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
  CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report third quarter 2025 financial results and corporate highlights after the U.S. financial markets close on Thursday, November 6, 2025. About Relay Therapeutics Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage, small molecule precision med
  Oct 30, 2025 - $RLAY
• Here's Why Relay Therapeutics, Inc. (RLAY) is a Great Momentum Stock to Buy
  Does Relay Therapeutics, Inc. (RLAY) have what it takes to be a top stock pick for momentum investors? Let's find out.
  Oct 28, 2025 - $RLAY
• Wall Street Analysts Believe Relay Therapeutics (RLAY) Could Rally 116.91%: Here's is How to Trade
  The mean of analysts' price targets for Relay Therapeutics (RLAY) points to an 116.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
  Oct 14, 2025 - $RLAY
• Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608
  In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Relay Therapeutics, Inc. is one of them. Relay Therapeutics, Inc. (NASDAQ:RLAY) is advancing its position in AI-powered oncology with a focus on targeting protein dynamics through computational modeling, structural biology, and molecular simulations. Its proprietary platform […]
  Sep 21, 2025 - $RLAY
• Barfresh Food Group Among 3 Promising Penny Stocks
  As the U.S. stock market reaches new heights, driven by a surge in technology stocks and record highs across major indices, investors are exploring diverse opportunities beyond the well-known giants. Penny stocks, often representing smaller or newer companies, continue to captivate interest due to their potential for significant returns despite being considered a somewhat outdated term. In this article, we examine three penny stocks that not only demonstrate robust financial health but also...
  Sep 19, 2025 - $RLAY
• Guggenheim Gives Buy Rating to Relay Therapeutics (RLAY)
  Relay Therapeutics, Inc. (NASDAQ:RLAY) is one of the Top 10 Stocks Under $10 That Could Triple. On September 4, Guggenheim began coverage of Relay Therapeutics, Inc. (NASDAQ:RLAY) with a Buy rating and a price target of $15. Guggenheim analysts called Relay Therapeutics, Inc. (NASDAQ:RLAY) a “Best Idea” and questioned why it is trading below cash […]
  Sep 8, 2025 - $RLAY
• Why Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week
  The cancer-focused biotech has a bright future, according to one pundit.
  Sep 5, 2025 - $RLAY
• Will Relay Therapeutics (NASDAQ:RLAY) Spend Its Cash Wisely?
  Just because a business does not make any money, does not mean that the stock will go down. For example, although...
  Aug 30, 2025 - $RLAY
• Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
  CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in September: 2025 Wells Fargo Healthcare Conference on Thursday, September 4, 2025 at 2:15 p.m. ETMorgan Stanley 23rd Annual Global Conference on Wednesday, September
  Aug 28, 2025 - $RLAY